眼表鳞状上皮肿瘤初次不完全切除术后的病灶内及局部干扰素治疗 - Suppr

Suppr

超能文献

Intralesional and topical interferon therapy following incomplete primary excision of ocular surface squamous neoplasia.

作者信息

Rishi Pukhraj, Shields Carol L

机构信息

Shri Bhagwan Mahavir Vitreoretinal Services, Chennai, Tamil Nadu, India.

Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA, USA.

出版信息

Indian J Ophthalmol. 2016 Jun;64(6):460-1. doi: 10.4103/0301-4738.187677.

DOI:10.4103/0301-4738.187677

PMID:27488156

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4991180/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b183/4991180/b06df74adbcb/IJO-64-460-g001.jpg

相似文献

Intralesional and topical interferon therapy following incomplete primary excision of ocular surface squamous neoplasia.眼表鳞状上皮肿瘤初次不完全切除术后的病灶内及局部干扰素治疗

Indian J Ophthalmol. 2016 Jun;64(6):460-1. doi: 10.4103/0301-4738.187677.

Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.眼局部应用干扰素α-2b 在眼表面鳞状上皮肿瘤切除术后辅助治疗中的作用。

In Vivo. 2019 Nov-Dec;33(6):2211-2215. doi: 10.21873/invivo.11724.

Primary squamous cell carcinoma arising from palpebral conjunctiva: A rare presentation.原发性眼睑结膜鳞状细胞癌：一种罕见的表现。

Indian J Ophthalmol. 2018 Feb;66(2):304-306. doi: 10.4103/ijo.IJO_754_17.

Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.结膜鳞状细胞肿瘤术后局部应用丝裂霉素C

Cornea. 1999 Jan;18(1):59-62.

Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.局部应用干扰素或手术切除治疗原发性眼表鳞状上皮肿瘤

Ophthalmology. 2008 Aug;115(8):1297-302, 1302.e1. doi: 10.1016/j.ophtha.2008.01.006. Epub 2008 Feb 21.

Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection.手术切除后，局部使用干扰素α-2b滴眼液作为辅助治疗结膜黑色素瘤的长期随访

Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2271-2276. doi: 10.1007/s00417-017-3754-2. Epub 2017 Jul 27.

Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?结膜和角膜巨大眼表鳞状细胞瘤的局部化疗：是否需要手术？

Indian J Ophthalmol. 2018 Jan;66(1):55-60. doi: 10.4103/ijo.IJO_590_17.

Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.局部用丝裂霉素C和环孢素A联合治疗作为角膜和结膜上皮内瘤变及浸润性鳞状细胞癌手术辅助治疗的应用。

Cornea. 2011 Apr;30(4):486; author reply 486-7. doi: 10.1097/ICO.0b013e3181e2cf72.

Management of Ocular Surface Squamous Neoplasia with Topical and Intralesional Interferon Alpha 2B in Mexicans.墨西哥人眼表鳞状上皮肿瘤的局部及瘤内注射α-2B干扰素治疗

Nepal J Ophthalmol. 2018 Jul;10(20):143-150. doi: 10.3126/nepjoph.v10i2.18574.

Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.局部应用丝裂霉素-C治疗部分切除的眼表鳞状上皮肿瘤。

Arch Iran Med. 2009 Jan;12(1):55-9.

引用本文的文献

Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence.眼表鳞状上皮肿瘤的临床管理：当前证据综述

Ophthalmol Ther. 2018 Dec;7(2):247-262. doi: 10.1007/s40123-018-0140-z. Epub 2018 Jul 20.

本文引用的文献

Eyelid and ocular surface carcinoma: diagnosis and management.眼睑与眼表癌：诊断与治疗

Clin Dermatol. 2015 Mar-Apr;33(2):159-69. doi: 10.1016/j.clindermatol.2014.10.008.

Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.亚洲人群眼表鳞状细胞肿瘤的临床和病理特征。

Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2569-73. doi: 10.1007/s00417-013-2450-0. Epub 2013 Sep 5.

Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.81 例眼表鳞状上皮肿瘤应用干扰素治疗的结果：基于美国癌症联合委员会分类的评估。

Cornea. 2013 Mar;32(3):248-56. doi: 10.1097/ICO.0b013e3182523f61.

Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.结膜下/病变周围重组干扰素 α2b 治疗眼表面鳞状上皮肿瘤：10 年回顾。

Ophthalmology. 2010 Dec;117(12):2241-6. doi: 10.1016/j.ophtha.2010.03.052.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验